10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

5 Dividend Stocks Ready to Give Investors a Raise

10.17.14 | 10:28 AM

BALTIMORE (Stockpickr) -- There's an important lesson to be learned from the 7.7% decline that the S&P 500 has made from its all-time highs last ...

4 Big Stocks on Traders' Radars

10.17.14 | 03:17 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter